Tower Research Capital (TRC)’s Entero Therapeutics ENTO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.03K | Sell |
1,688
-2
| -0.1% | -$2 | ﹤0.01% | 4714 |
|
|
2025
Q1 | $2.43K | Buy |
1,690
+2
| +0.1% | +$3 | ﹤0.01% | 4551 |
|
|
2024
Q4 | $3.15K | Sell |
1,688
-807
| -32% | -$1.51K | ﹤0.01% | 4703 |
|
|
2024
Q3 | $2.57K | Buy |
2,495
+668
| +37% | +$689 | ﹤0.01% | 4969 |
|
|
2024
Q2 | $6.74K | Buy |
1,827
+1,029
| +129% | +$3.8K | ﹤0.01% | 4544 |
|
|
2024
Q1 | $10.5K | Sell |
798
-147
| -16% | -$1.93K | ﹤0.01% | 3692 |
|
|
2023
Q4 | $11.9K | Buy |
945
+759
| +408% | +$9.57K | ﹤0.01% | 4093 |
|
|
2023
Q3 | $3.24K | Buy |
186
+58
| +45% | +$1.01K | ﹤0.01% | 5034 |
|
|
2023
Q2 | $12.2K | Buy |
128
+53
| +71% | +$5.07K | ﹤0.01% | 3867 |
|
|
2023
Q1 | $12K | Buy |
75
+59
| +369% | +$9.44K | ﹤0.01% | 4137 |
|
|
2022
Q4 | $6K | Buy |
16
+8
| +100% | +$3K | ﹤0.01% | 4788 |
|
|
2022
Q3 | $5K | Buy |
+8
| New | +$5K | ﹤0.01% | 5184 |
|
|
2022
Q2 | – | Hold |
0
| – | -$6K | – | 5877 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 4942 |
|
|
2021
Q4 | – | Hold |
0
| – | -$7K | – | 6642 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 4684 |
|
|
2021
Q2 | – | Sell |
-1
| Closed | -$209K | – | 5903 |
|
|
2021
Q1 | $209K | Buy |
+1
| New | +$209K | ﹤0.01% | 1976 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 4450 |
|
|
2020
Q3 | – | Hold |
0
| – | -$14K | – | 5151 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 3878 |
|